Please wait ...

Anne Wagner, PhD, C Psych

Anne Wagner, PhD, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (, a centre for mental health innovation.


Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy. She is an adjunct professor, department of Psychology at Ryerson University. Dr. Wagner is an associate member, Yeates School of Graduate Studies at Ryerson University.
Non-financial: Anne Wagner serves on the board of directors for Casey House. She is a member of the Canadian Psychological Association – Traumatic Stress Section; International Society of Traumatic Stress Studies; the Ontario Psychological Association; International Society for Psychedelic Research; and the Association for Behavioral and Cognitive Therapies – Trauma and PTSD Special Interest Group.


The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress

Michael Mithoefer, MD |  Rick Doblin, Ph.D. |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, Ph.D. |  Anne Wagner, PhD, C Psych |  ....
3 Hours 59 Minutes
May 18, 2021
Product Code:
Media Type:
Digital Seminar
$119.95 - Trauma Sale Standard - $199.95

Showing 1 to 1 of 1 entries